I think your characterization of drug companies is unfair.
There are a lot of things that make it tough for drug companies to provide drug for compassionate use (before FDA approval). Often early on manufacturing hasn't been developed enough to make large quantities of drug. If they give drug to everyone who asks for it, they won't have enough to run their trials. What is the impact of that?
There are a lot of things that make it tough for drug companies to provide drug for compassionate use (before FDA approval). Often early on manufacturing hasn't been developed enough to make large quantities of drug. If they give drug to everyone who asks for it, they won't have enough to run their trials. What is the impact of that?